Trade-Ideas: Integra Lifesciences Holdings (IART) Is Today's Strong And Under The Radar Stock

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified Integra Lifesciences Holdings ( IART) as a strong and under the radar candidate. In addition to specific proprietary factors, Trade-Ideas identified Integra Lifesciences Holdings as such a stock due to the following factors:

  • IART has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $15.1 million.
  • IART is making at least a new 3-day high.
  • IART has a PE ratio of 57.
  • IART is mentioned 0.84 times per day on StockTwits.
  • IART has not yet been mentioned on StockTwits today.
  • IART is currently in the upper 20% of its 1-year range.
  • IART is in the upper 35% of its 20-day range.
  • IART is in the upper 45% of its 5-day range.
  • IART is currently trading above yesterday's high.

'Strong and Under the Radar' stocks tend to be worthwhile stocks to watch for a variety of factors including historical back testing and price action. Market technicians refer to such stocks as being in an accumulation phase before a mark-up and peak. Traders and hedge funds have frequently found that these types of stocks continue to build a solid price base and then ultimately spike higher and peak when others 'discover' how good the stock is performing. By leveraging the social discovery aspect of StockTwits we are highlighting stocks that don't currently receive much attention from retail investors, but we suspect may soon garner more attention.

If you liked this article you might like

Johnson & Johnson Signals It Could Make Additional Divestitures

Integra's Massive Run-Up Expected to Continue as J&J's Surgical Business Joins the Fold

Integra Scoops up JNJ's Codman Neurosurgery for $1.05 Billion

Integra Scoops Up JNJ's Codman Neurosurgery for $1.05 Billion

Derma Sciences Soars Almost 40% on Buyout by Integra